Business Context and Reporting Period
This Form 6-K filing by GSK plc, dated March 19, 2025, reports a transaction in the company's own shares. The filing details a share repurchase executed on March 18, 2025, as part of an existing buyback programme.
Key Financial Metrics
The filing focuses exclusively on capital allocation activities regarding share repurchases. It does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics.
- Shares Purchased (March 18, 2025): 552,000 ordinary shares.
- Price Range: Lowest 1,529.00 GBp; Highest 1,539.50 GBp.
- Volume-Weighted Average Price: 1,535.17 GBp.
- Trading Venue: London Stock Exchange (XLON).
- Treasury Shares Held: 180,828,770 (post-transaction).
- Shares in Issue (excluding Treasury): 4,134,376,522.
- Total Voting Rights: 4,134,376,522.
Material Changes
The filing reports a continuation of the non-discretionary buyback agreement entered into with Citigroup Global Markets Limited on February 24, 2025.
- Cumulative Purchases: Since February 24, 2025, the Company has purchased 11,758,467 ordinary shares.
- Treasury Position: The March 18 transaction increased the total treasury share count to 180,828,770.
Guidance, Outlook, and Risks
The filing contains no new financial guidance, outlook, or management commentary regarding operational performance. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially due to risks described in the GSK 2024 Annual Report on Form 20-F (pages 277 to 285).
Investor Verification Checklist
- Verify the total remaining authorization under the current buyback programme against the 11.76 million shares purchased since February 24, 2025.
- Confirm the impact of the 180.8 million treasury shares on earnings per share (EPS) calculations.
- Review the GSK 2024 Annual Report on Form 20-F for the specific risk factors referenced in the cautionary statement.
- Monitor subsequent filings for updates on the completion or extension of the non-discretionary agreement with Citigroup.